Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OmniAb (OABI)

OmniAb Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OABI
DateTimeSourceHeadlineSymbolCompany
04/06/202412:20Business WireOmniAbが重鎖単一ドメイン抗体ニワトリプラットフォームに関する学術論文を米国免疫学会雑誌に発表NASDAQ:OABIOmniAb Inc
03/06/202421:05Business WireOmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of ImmunologyNASDAQ:OABIOmniAb Inc
20/05/202413:05Business WireOmniAb to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:OABIOmniAb Inc
15/05/202421:05Business WireOmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston SummitNASDAQ:OABIOmniAb Inc
09/05/202421:05Business WireOmniAb Reports First Quarter 2024 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
01/05/202413:00Business WireOmniAb to Participate in Five Investor Conferences in MayNASDAQ:OABIOmniAb Inc
22/04/202413:00Business WireOmniAb to Report First Quarter 2024 Financial Results on May 9NASDAQ:OABIOmniAb Inc
20/03/202420:05Business WireOmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
26/02/202413:00Business WireOmniAb to Report Fourth Quarter 2023 Financial Results on March 20NASDAQ:OABIOmniAb Inc
20/02/202413:00Business WireOmniAb to Participate in Two Investor Conferences in MarchNASDAQ:OABIOmniAb Inc
14/12/202321:30Business WireOmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics ConferenceNASDAQ:OABIOmniAb Inc
09/11/202322:55Business WireOmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual EventNASDAQ:OABIOmniAb Inc
09/11/202313:00Business WireOmniAb Reports Third Quarter 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
02/11/202312:00Business WireOmniAb to Participate in Two Investor Conferences in NovemberNASDAQ:OABIOmniAb Inc
01/11/202313:00Business WireOmniAb Appoints Steve Love to its Board of DirectorsNASDAQ:OABIOmniAb Inc
31/10/202320:28Business WireOmniAb Announces Agenda for its Research & Technology Virtual EventNASDAQ:OABIOmniAb Inc
12/10/202313:00Business WireOmniAb to Hold Research & Technology Virtual Event on November 9NASDAQ:OABIOmniAb Inc
05/09/202313:00Business WireOmniAb to Participate in Two Investor Conferences in SeptemberNASDAQ:OABIOmniAb Inc
10/08/202321:05Business WireOmniAb Reports Second Quarter 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
07/08/202321:05Business WireOmniAb Announces the Passing of Director Sunil PatelNASDAQ:OABIOmniAb Inc
31/07/202313:00Business WireOmniAb to Report Second Quarter 2023 Financial Results on August 10NASDAQ:OABIOmniAb Inc
17/05/202321:05Business WireOmniAb Launches OmniDeep™ at the PEGS Boston Conference and ExpoNASDAQ:OABIOmniAb Inc
11/05/202312:00Business WireOmniAb Reports First Quarter 2023 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
01/05/202313:00Business WireOmniAb to Report First Quarter 2023 Financial Results on May 11NASDAQ:OABIOmniAb Inc
25/04/202313:00Business WireOmniAb to Participate in Upcoming Investor Conferences in MayNASDAQ:OABIOmniAb Inc
30/03/202321:05Business WireOmniAb Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsNASDAQ:OABIOmniAb Inc
09/03/202313:00Business WireOmniAb to Report Fourth Quarter 2022 Financial Results on March 30NASDAQ:OABIOmniAb Inc
07/02/202313:00Business WireOmniAb to Participate in Three Upcoming Investor ConferencesNASDAQ:OABIOmniAb Inc
01/12/202213:47GlobeNewswire Inc.Hillstream BioPharma Announces Development of Proprietary Targeted Biologics, Knob Quatrabodies™ (HSB-1940) against PD-1, by combining Quatramers™ with OmniAb’s Picobodies™, via a Collaboration Agreement, against Novel, Unreachable and UndruggableNASDAQ:OABIOmniAb Inc
15/11/202212:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OABIOmniAb Inc
 Showing the most relevant articles for your search:NASDAQ:OABI